DBV Technologies (DBVT) Net Income towards Common Stockholders (QoQ) (2020 - 2026)
DBV Technologies (DBVT) Net Income towards Common Stockholders (QoQ) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
DBV Technologies |
6.63 Bn |
6.41 Bn |
-3.90 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
-6.18% |
| Dec 31, 2025 |
-35.17% |
| Sep 30, 2025 |
20.80% |
| Jun 30, 2025 |
-54.52% |
| Mar 31, 2025 |
-17.75% |
| Dec 31, 2024 |
24.40% |
| Sep 30, 2024 |
8.07% |
| Jun 30, 2024 |
-21.10% |
| Mar 31, 2024 |
-144.46% |
| Dec 31, 2023 |
33.16% |
| Sep 30, 2023 |
30.97% |
| Jun 30, 2023 |
-17.91% |
| Mar 31, 2023 |
47.60% |
| Dec 31, 2022 |
-127.00% |
| Sep 30, 2022 |
24.97% |
| Jun 30, 2022 |
-37.91% |
| Mar 31, 2022 |
-22.19% |
| Dec 31, 2021 |
43.11% |
| Sep 30, 2021 |
21.60% |
| Jun 30, 2021 |
-4.09% |
